Subscribe
Dublin-The FDA has classified a new microplasmin compound for use in pediatric vitrectomy as an orphan drug.
Stepladder approach indicated in pediatric uveitis
Penalization can play a useful role in treatment of amblyopia
Weisenfeld Award winner highlights the success behind retinoblasma treatment, survival rate
ARVO 2004 Retina presentations
Basil Williams, MD; Maura Di Nicola, MD
Deep Parikh, MD
Uday Devgan, MD, FACS, FRCS
Carl J. Danzig, MD, FASRS